Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Fassan

Showing results (581-590 of 596) with videos related to

Pageof 60
Sort By:
Science (New York, N.Y.)|February 24, 2018
Patient-derived organoids model treatment response of metastatic gastrointestinal cancersGeorgios Vlachogiannis, Somaieh Hedayat, Alexandra Vatsiou, et al.
Cancer Cytopathology|May 6, 2017
Consistency and reproducibility of next-generation sequencing and other multigene mutational assays: A worldwide ring trial study on quantitative cytological molecular reference specimensUmberto Malapelle, Clara Mayo-de-Las-Casas, Miguel A Molina-Vila, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 20, 2024
Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652-3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal CancerSomaieh Hedayat, Luciano Cascione, David Cunningham, et al.
Cancer Cell|September 20, 2024
Coagulation factor X promotes resistance to androgen-deprivation therapy in prostate cancerBianca Calì, Martina Troiani, Silvia Bressan, et al.
Virchows Archiv : an International Journal of Pathology|November 10, 2020
Multi-center real-world comparison of the fully automated Idylla™ microsatellite instability assay with routine molecular methods and immunohistochemistry on formalin-fixed paraffin-embedded tissue of colorectal cancerAna Velasco, Fatma Tokat, Jesper Bonde, et al.
International Journal of Surgery (London, England)|April 24, 2023
IMMUNOREACT 5: female patients with rectal cancer have better immune editing mechanisms than male patients - a cohort studyGaya Spolverato, Matteo Fassan, Giulia Capelli, et al.
The British Journal of Surgery|July 21, 2023
IMMUNOREACT 6: weak immune surveillance characterizes early-onset rectal cancerGaya Spolverato, Matteo Fassan, Melania Scarpa, et al.
Oncology and Therapy|January 10, 2024
Non-Small Cell Lung Cancer Testing on Reference Specimens: An Italian Multicenter ExperienceFrancesco Pepe, Gianluca Russo, Alessandro Venuta, et al.
Journal of Personalized Medicine|May 28, 2022
Validation of a Novel Three-Dimensional (<i>3D Fusion</i>) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 StudyMatteo Brunelli, Guido Martignoni, Giorgio Malpeli, et al.
Cancer|April 22, 2024
IMMUNOREACT 7: Regular aspirin use is associated with immune surveillance activation in colorectal cancerOttavia De Simoni, Melania Scarpa, Ignazio Castagliuolo, et al.
Pageof 60

Showing results (581-590 of 596) with videos related to

Sort By:
Pageof 60
Science (New York, N.Y.)|February 24, 2018
Patient-derived organoids model treatment response of metastatic gastrointestinal cancersGeorgios Vlachogiannis, Somaieh Hedayat, Alexandra Vatsiou, et al.
Cancer Cytopathology|May 6, 2017
Consistency and reproducibility of next-generation sequencing and other multigene mutational assays: A worldwide ring trial study on quantitative cytological molecular reference specimensUmberto Malapelle, Clara Mayo-de-Las-Casas, Miguel A Molina-Vila, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 20, 2024
Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652-3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal CancerSomaieh Hedayat, Luciano Cascione, David Cunningham, et al.
Cancer Cell|September 20, 2024
Coagulation factor X promotes resistance to androgen-deprivation therapy in prostate cancerBianca Calì, Martina Troiani, Silvia Bressan, et al.
Virchows Archiv : an International Journal of Pathology|November 10, 2020
Multi-center real-world comparison of the fully automated Idylla™ microsatellite instability assay with routine molecular methods and immunohistochemistry on formalin-fixed paraffin-embedded tissue of colorectal cancerAna Velasco, Fatma Tokat, Jesper Bonde, et al.
International Journal of Surgery (London, England)|April 24, 2023
IMMUNOREACT 5: female patients with rectal cancer have better immune editing mechanisms than male patients - a cohort studyGaya Spolverato, Matteo Fassan, Giulia Capelli, et al.
The British Journal of Surgery|July 21, 2023
IMMUNOREACT 6: weak immune surveillance characterizes early-onset rectal cancerGaya Spolverato, Matteo Fassan, Melania Scarpa, et al.
Oncology and Therapy|January 10, 2024
Non-Small Cell Lung Cancer Testing on Reference Specimens: An Italian Multicenter ExperienceFrancesco Pepe, Gianluca Russo, Alessandro Venuta, et al.
Journal of Personalized Medicine|May 28, 2022
Validation of a Novel Three-Dimensional (<i>3D Fusion</i>) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 StudyMatteo Brunelli, Guido Martignoni, Giorgio Malpeli, et al.
Cancer|April 22, 2024
IMMUNOREACT 7: Regular aspirin use is associated with immune surveillance activation in colorectal cancerOttavia De Simoni, Melania Scarpa, Ignazio Castagliuolo, et al.
Pageof 60